Grants and Contracts Details
Description
Contact PD/PI: Messaoudi Powers, Ilhem
SUMMARY
Varicella zoster virus (VZV) is a highly contagious, neurotropic alpha herpes virus that causes
varicella (chickenpox). VZV establishes latency in the sensory ganglia from which it can reactivate
to cause herpes zoster (shingles), a painful disease that affects almost 1 million individuals in the
United States annually. During primary infection VZV is transmitted through the inhalation of viral
particles, but the mechanisms by which VZV traffics from the initial site of infection to the ganglia
and skin remain unclear. Data from in vitro assays as well as in vivo studies using severe-
combined immunodeficient mice implanted with human fetal tissues (SCID-hu) strongly suggest
that T cells are highly susceptible to VZV infection and may play a critical role in VZV
dissemination to the skin and ganglia. However, the SCID-hu mouse model has two major
limitations: 1) the lack of an adaptive immune system and 2) the possibility that the strict human
host specificity of VZV could have altered viral behavior in this murine model. Additionally, in vitro
studies of human tonsillar T cells were carried out using the attenuated Oka vaccine strain, which
may not adequately model the outcome of infection with wild type viral strains. In this application,
we propose to define the mechanisms by which VZV usurps T cells to spread by using a rhesus
macaque model that recapitulates the hallmarks of VZV infection. In this model, rhesus macaques
are intra-bronchially infected with Simian varicella virus (SVV), a homolog of VZV. We have
demonstrated that lung-resident T cells are susceptible and permissive to SVV infection.
Additionally, memory T cells are detected in the ganglia as early as 3 days post-infection, at the
same time as viral DNA and before the detection of a viral-specific T cell response. Although
these observations establish a significant role for T cells in SVV spread to the ganglia, as
has been suggested for VZV, the mechanism by which varicella viruses hijack the host’s
T cells to disseminate to latency sites remain poorly defined. In this application, we will
address this critical knowledge gap by first identifying transcriptional changes induced by SVV
infection in T cells isolated from the lung during acute infection using high throughput single cell
RNA sequencing. Then, we will assess alterations in metabolic and migratory function of SVV-
infected T cells in vitro. Completion of the studies proposed in this application will yield novel
insight into viral-host interactions at the single cell level and will serve as a model to investigate
the pathogenesis of other T cell tropic viruses.
Page 6
Project Summary/Abstract
Status | Finished |
---|---|
Effective start/end date | 12/1/21 → 5/31/22 |
Funding
- National Institute of Allergy and Infectious Diseases: $68,480.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.